Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Acute Respiratory Failure-IV01:23

Acute Respiratory Failure-IV

348
Respiratory failure can manifest suddenly or gradually, characterized by a rapid decline in PaO2 and a rapid rise in PaCO2. This situation indicates a severe respiratory problem that may quickly become a life-threatening emergency. One of the early signs of hypoxemic Acute Respiratory Failure (ARF) is a change in mental status due to the brain's sensitivity to oxygen levels and changes in acid-base balance. Symptoms such as restlessness, confusion, and agitation suggest inadequate oxygen...
348
Mechanical Ventilation II: Invasive Ventilation01:23

Mechanical Ventilation II: Invasive Ventilation

417
Ventilators are essential medical equipment used to aid patients with respiratory difficulties. Their primary function is to assist or replace spontaneous breathing by providing mechanical ventilation. There are two general classes of mechanical ventilators: negative-pressure and positive-pressure ventilators.
Negative-Pressure Ventilators
Negative-pressure ventilators create a vacuum around the chest or body to draw air into the lungs, simulating breathing. This method does not require an...
417
Acute Respiratory Failure-III01:30

Acute Respiratory Failure-III

485
Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without...
485
Acute Respiratory Failure-II01:21

Acute Respiratory Failure-II

643
Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
643
Acute Respiratory Failure-V01:29

Acute Respiratory Failure-V

286
The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
286
Mechanical Ventilation III: Noninvasive Ventilation01:23

Mechanical Ventilation III: Noninvasive Ventilation

355
Noninvasive positive-pressure ventilation (NIPPV), continuous positive airway pressure (CPAP), and bilevel positive airway pressure (BiPAP) are essential methods in respiratory care. These ventilation techniques offer unique benefits for patients with various respiratory conditions, providing adequate support without requiring intubation. Let's explore how each method is crucial in improving patient outcomes and enhancing respiratory therapy.
Noninvasive Positive-Pressure Ventilation...
355

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The effectiveness of tissue-perfusion-guided resuscitation in shock: A systematic review and meta-analysis.

Annals of intensive care·2026
Same author

Machine learning models predicting extubation success in mechanically ventilated patients: a systematic review and meta-analysis.

Intensive care medicine experimental·2026
Same author

ElecTrical Impedance TomogRaphy vs dynamic compliANce guided positive end-expiratory pressure Titration during laparoscopic gynaecological surgery (TITRANT): protocol for a multicentre randomised trial.

BMJ open·2026
Same author

The role of hemoadsorption in septic shock: toward a personalized approach.

Critical care (London, England)·2026
Same author

Evaluation of the diagnostic value of the Modified Evan's Blue Dye Test for assessing aspiration in tracheostomized critically ill patients: A systematic review and meta-analysis.

PloS one·2026
Same author

KInetics of Procalcitonin to Reduce Unnecessary aNtibiotic use (KIPRUN): protocol for a multicentre, randomised, superiority trial to compare the efficacy and safety of procalcitonin kinetics-guided and absolute procalcitonin value-guided antibiotic initiation in critically ill patients.

BMJ open·2026

Related Experiment Video

Updated: Nov 13, 2025

Veno-Venous Extracorporeal Membrane Oxygenation in a Mouse
06:41

Veno-Venous Extracorporeal Membrane Oxygenation in a Mouse

Published on: October 24, 2018

12.8K

Extracorporeal membrane oxygenation in intensive care unit

Éva Zöllei1,2, Gábor Bari3, Ivett Blaskovics4,5

  • 11 Szegedi Tudományegyetem, Általános Orvostudományi Kar, Aneszteziológiai és Intenzív Terápiás Intézet, Szeged.

Orvosi Hetilap
|March 14, 2021
PubMed
Summary

Extracorporeal membrane oxygenation (ECMO) is a vital treatment for severe respiratory and circulatory failure. This study demonstrates that implementing ECMO programs in Hungarian centers yields survival rates comparable to international benchmarks.

Keywords:
extracorporalis membránoxigenizációextracorporeal membrane oxygenationintensive therapyintenzív kezeléslégzési elégtelenségrespiratory insufficiency

More Related Videos

Point-of-Care Ultrasound for Peripheral Veno-Arterial Extracorporeal Membrane Oxygenation Without Left Ventricular Venting
03:40

Point-of-Care Ultrasound for Peripheral Veno-Arterial Extracorporeal Membrane Oxygenation Without Left Ventricular Venting

Published on: January 17, 2025

566
Monitoring Lung Function with Electrical Impedance Tomography in the Intensive Care Unit
05:56

Monitoring Lung Function with Electrical Impedance Tomography in the Intensive Care Unit

Published on: September 6, 2024

5.1K

Related Experiment Videos

Last Updated: Nov 13, 2025

Veno-Venous Extracorporeal Membrane Oxygenation in a Mouse
06:41

Veno-Venous Extracorporeal Membrane Oxygenation in a Mouse

Published on: October 24, 2018

12.8K
Point-of-Care Ultrasound for Peripheral Veno-Arterial Extracorporeal Membrane Oxygenation Without Left Ventricular Venting
03:40

Point-of-Care Ultrasound for Peripheral Veno-Arterial Extracorporeal Membrane Oxygenation Without Left Ventricular Venting

Published on: January 17, 2025

566
Monitoring Lung Function with Electrical Impedance Tomography in the Intensive Care Unit
05:56

Monitoring Lung Function with Electrical Impedance Tomography in the Intensive Care Unit

Published on: September 6, 2024

5.1K

Area of Science:

  • Cardiovascular and Respiratory Medicine
  • Intensive Care Medicine
  • Extracorporeal Life Support

Background:

  • Extracorporeal membrane oxygenation (ECMO) is increasingly utilized globally for refractory respiratory and circulatory failure.
  • The establishment of an ECMO program requires careful planning and execution, integrating physiological principles with clinical application.
  • Veno-venous (VV) configuration is a primary mode for respiratory support, while veno-arterial (VA) configuration supports both respiratory and circulatory functions.

Purpose of the Study:

  • To review the physiological basis of extracorporeal membrane oxygenation (ECMO), particularly the veno-venous configuration.
  • To present the initial outcomes of patients treated with ECMO at our institution.
  • To assess the feasibility and effectiveness of establishing an ECMO program in a tertiary care setting.

Main Methods:

  • Systematic review of the existing literature on extracorporeal membrane oxygenation.
  • Retrospective analysis of data from 14 patients treated with ECMO since 2016.
  • Evaluation of patient demographics, indications for ECMO, configuration used, duration of support, and patient outcomes.

Main Results:

  • Fourteen patients (8 male, mean age 51 ± 15 years) received ECMO support, primarily for refractory hypoxemic respiratory failure (9 cases).
  • Respiratory support was provided in 11 patients (13 VV, 1 VA) for a mean of 14 ± 6 days; circulatory support in 3 patients for a mean of 5 ± 4 days.
  • Nine patients were discharged in good functional condition; 5 died during intensive care, and 3 died later during hospitalization, indicating feasibility and comparable survival rates to international data.

Conclusions:

  • The implementation of an extracorporeal membrane oxygenation program is achievable in Hungarian tertiary centers.
  • Adherence to international recommendations and training standards allows for survival outcomes similar to those reported globally.
  • ECMO is a viable and effective treatment modality for severe respiratory and circulatory failure, contributing to improved patient outcomes.